» Articles » PMID: 23160653

Supra-physiological Doses of Testosterone Affect Membrane Oxidation of Human Neutrophils Monitored by the Fluorescent Probe C₁₁-BODIPY⁵⁸¹/⁵⁹¹

Overview
Specialty Physiology
Date 2012 Nov 20
PMID 23160653
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

The purpose of this study was to determine the effects of supra-physiological doses of testosterone (TES) on membrane oxidation of activated human neutrophils in vitro using an innovative and sensitive technique: the real-time detection with the fluorescence probe C11-BODIPY(581/591). Methodological controls were performed with the lipid-soluble and powerful antioxidant astaxanthin at different neutrophil density cultures. Neutrophils from nine healthy young men (23.4 ± 2.5 years, 174.4 ± 7.0 cm height, and 78.3 ± 7.0 kg weight) were isolated and treated with 0.1 or 10 μM TES for 24 h and subsequently labeled with the free radical-sensitive probe C11-BODIPY(581/591) for monitoring membrane oxidation after neutrophil activation with phorbol-12-myristate-13-acetate (PMA). First-order exponential decay kinetic indicated that both 0.1 and 10 μM TES severely increased baseline membrane oxidation in non-activated human neutrophils (compared to control). However, similar kinetics of membrane oxidation were observed in control and 0.1 μM TES-treated neutrophils after PMA activation, whereas chemical activation did not alter the baseline higher rates of membrane oxidation in 10 μM TES-treated neutrophils. The data presented here support the hypothesis that TES exerts distinct effects on the membrane oxidation of human neutrophils, depending on its dose (here, 10(2) to 10(4)-fold higher than physiological levels in men) and on PMA activation of the oxidative burst. Furthermore, this paper also presents an innovative application of the free radical-sensitive probe C11-BODIPY(581/591) for monitoring (auto-induced) membrane oxidation as an important parameter of viability and, thus, responsiveness of immune cells in inflammatory processes.

Citing Articles

Antioxidant Interactions between Citrus Fruit Carotenoids and Ascorbic Acid in New Models of Animal Cell Membranes.

Barros M, Zacarias-Garcia J, Rey F, Zacarias L, Rodrigo M Antioxidants (Basel). 2023; 12(9).

PMID: 37760036 PMC: 10525925. DOI: 10.3390/antiox12091733.


Activation of ALOX12 by a multi-organelle-orienting photosensitizer drives ACSL4-independent cell ferroptosis.

Wang X, Chen Y, Yang X, Cheng L, He Z, Xin Y Cell Death Dis. 2022; 13(12):1040.

PMID: 36517470 PMC: 9751149. DOI: 10.1038/s41419-022-05462-9.


Reactive oxygen species: players in the cardiovascular effects of testosterone.

Tostes R, Carneiro F, Carvalho M, Reckelhoff J Am J Physiol Regul Integr Comp Physiol. 2015; 310(1):R1-14.

PMID: 26538238 PMC: 4796634. DOI: 10.1152/ajpregu.00392.2014.


The effect of sample storage on the Peroxidation of Leukocytes Index Ratio (PLIR) measure.

Peluso I, Manafikhi H, Altieri F, Zanza C, Palmery M Sci Rep. 2014; 4:6539.

PMID: 25290094 PMC: 5377464. DOI: 10.1038/srep06539.


Neuroprotective properties of the marine carotenoid astaxanthin and omega-3 fatty acids, and perspectives for the natural combination of both in krill oil.

Barros M, Poppe S, Bondan E Nutrients. 2014; 6(3):1293-317.

PMID: 24667135 PMC: 3967194. DOI: 10.3390/nu6031293.

References
1.
Aldini G, Yeum K, Russell R, Krinsky N . A method to measure the oxidizability of both the aqueous and lipid compartments of plasma. Free Radic Biol Med. 2001; 31(9):1043-50. DOI: 10.1016/s0891-5849(01)00684-0. View

2.
Axell A, MacLean H, Plant D, Harcourt L, Davis J, Jimenez M . Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab. 2006; 291(3):E506-16. DOI: 10.1152/ajpendo.00058.2006. View

3.
Basaria S, Wahlstrom J, Dobs A . Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001; 86(11):5108-17. DOI: 10.1210/jcem.86.11.7983. View

4.
Dillon E, Durham W, Urban R, Sheffield-Moore M . Hormone treatment and muscle anabolism during aging: androgens. Clin Nutr. 2010; 29(6):697-700. PMC: 2964430. DOI: 10.1016/j.clnu.2010.03.010. View

5.
Hoffman J, Kraemer W, Bhasin S, Storer T, Ratamess N, Haff G . Position stand on androgen and human growth hormone use. J Strength Cond Res. 2009; 23(5 Suppl):S1-S59. DOI: 10.1519/JSC.0b013e31819df2e6. View